๐๐ฅ๐จ๐๐๐ฅ ๐๐๐ฌ๐ฉ๐ข๐ซ๐๐ญ๐จ๐ซ๐ฒ ๐๐๐ฏ๐ข๐๐๐ฌ ๐๐๐ซ๐ค๐๐ญ
๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ
Some of the most often used respiratory devices are inhalers, nebulizer treatments, oxygen reflectors, positive airway pressure (PAP) devices, motorized ventilators, pulse oximeters, polysomnography devices, and spirometers.
The global respiratory devices market is anticipated to reach US$ 34,178.1 million by the end of 2027, with a value of US$ 16,878.0 million in 2019.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ญ โhttps://www.coherentmarketinsights.com/insight/request-sample/1299
๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ
During the forecast period, rising air pollution is projected to drive the global respiratory devices market’s development. Air pollution (PM2.5, ozone, and home air pollution) is the sixth largest cause of death globally, according to the Health Effects Institute’s State of Global Air 2019 study.
๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ
Players in the global respiratory devices market may anticipate attractive development possibilities if they invest and fund R&D for breathing problems. Peter Weiss AO, an Australian businessman and arts patron, committed US$ 4 million in support for essential lung disease research in February 2020.
๐๐๐ฌ๐ญ๐ซ๐๐ข๐ง๐ญ๐ฌ
Critical mistakes in inhalation testing are common in respiratory devices, which is anticipated to stymie market expansion. Inhaler handling errors can have a negative influence on medication delivery and treatment effectiveness. Lack of drug adherence is also estimated to restrict market expansion. When compared to other chronic illnesses, asthma and COPD have poorer adherence rates.
๐๐๐ฒ ๐๐๐ค๐๐๐ฐ๐๐ฒ๐ฌ
The positive airway pressure devices segment of the global respiratory devices market was worth US$ 4,551.5 million in 2018 and is projected to grow at a CAGR of 11.1 percent to US$ 11,814.6 million by 2027. During the forecast period, the segment’s growth will continue to be aided by an increase in product releases.
The portable oxygen concentrators sub segment held the leading position in the oxygen concentrators segment in the global respiratory devices market in 2018, contributing for 66.6 percent share in terms of value, preceded by home oxygen concentrators. Future product releases are anticipated to drive the growth of this category.
In terms of value, the pulse oximeters sector accounted for 12.7 percent of the worldwide respiratory devices market. The pulse oximeters sub-segment is projected to rise as regulatory approvals for pulse oximeters increase. Masimo obtained FDA authorization for their O3 Regional Oximetry product’s newborn application in June 2019.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐๐ซ๐ ๐๐๐ ๐๐ซ๐จ๐๐ก๐ฎ๐ซ๐ @ย https://www.coherentmarketinsights.com/insight/request-pdf/1299
๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐ง๐๐ฌ
The global respiratory devices market’s major players are concentrating on the development and introduction of new products. Pulmogine, a mesh nebulizer, was introduced at the 2019 ERS International Congress by HCmed Innovations Co., Inc., a drug-device combination business.
Product recalls are anticipated to stifle market expansion. Teleflex Incorporated issued a global voluntary recall of the COMFORT FLO Humidification System in February 2020, citing the risk of water flooding the section and entering the circuit if an unusual pressure drop is formed between the water bottle and the section all through high-flow oxygen therapy.
๐๐๐ ๐ฎ๐ฅ๐๐ญ๐ข๐จ๐ง
๐๐ฎ๐ซ๐จ๐ฉ๐
โข Medical gas systems need to be CE Certified and Labelled in accordance with Council Directive 93/42 EEC Concerning Medical Devices (Class IIB); 2006/42 EC Machinery Directive; 97/23/EEC Pressure Equipment Directive (PED) and 2006/95/EC, Low Voltage Electrical Equipment Directive (LVD)
โข In Europe, the MOS systems are treated as medical devices and classified as IIB
โข They require a CE mark for legal marketing. However, the CE Marking process will change as Europeโs new Medical Device Regulation (MDR) comes into force in May 2020
Implementation, modification, and maintenance of a quality system (usually ISO 13485) that will meet European and other international requirements are further specifications
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฉ๐จ๐ซ๐ญ โhttps://www.coherentmarketinsights.com/insight/buy-now/1299
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐
Key companies contributing in the global respiratory devices market are Hamilton Medical AG, ResMed. Inc., Fisher & Paykel Healthcare Limited, General Electric Healthcare Limited, Masimo Corporation, Inogen Inc., Teleflex Incorporated, Drรคgerwerk AG & Co. KGaA, Smiths Medical, Koninklijke Philips N.V., and Medtronic PLC.
๐๐๐ฒ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ๐ฌ
June 2019: Rapid Oxygen collaborated with the Connecticut Alliance of Boys & Girls Clubs to donate its R15, a portable oxygen cylinder.
February 2020: Medtronic Pharmaceuticals stated that the firm and the Medtronic Foundation are donating about US$ 1.2 million to coronavirus disaster relief globally.
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: [email protected]
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837